# Karyopharm Therapeutics Inc. (KPTI)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KPTI/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 35.07M | $ -22.39M | $ -22.73M | N/A | $ -265.65M |
| 2025 | $ 149.56M | $ -200.73M | $ -77.17M | $ 233.61M | $ -292.93M |
| 2024 | $ 152.66M | $ -80.33M | $ -134.15M | $ 194.52M | $ -186.02M |
| 2023 | $ 157.90M | $ -154.73M | $ -100.26M | $ 177.02M | $ -136.21M |
| 2022 | $ 175.47M | $ -184.65M | $ -167.11M | $ 179.07M | $ -16.66M |
| 2021 | $ 249.40M | $ -147.50M | $ -127.58M | $ 180.58M | $ -79.67M |
| 2020 | $ 137.69M | $ -250.04M | $ -204.31M | $ 131.13M | $ 50.55M |
| 2019 | $ 52.78M | $ -257.62M | $ -246.57M | $ 124.71M | $ 49.77M |
| 2018 | $ 40.06M | $ -235.62M | $ -213.26M | $ 102.66M | $ 183.17M |
| 2017 | $ 2.16M | $ -173.76M | $ -99.39M | $ 0 | $ 129.46M |
| 2016 | $ 211.9K | $ -150.76M | $ -116.20M | $ 0 | $ 162.24M |
| 2015 | $ 351.0K | $ -165.93M | $ -134.01M | $ 0 | $ 198.37M |
| 2014 | $ 323.6K | $ -107.07M | $ -76.70M | $ 0 | $ 206.79M |
| 2013 | $ 550.4K | $ -48.28M | $ -43.16M | $ 0 | $ 154.93M |
| 2012 | $ 96.7K | $ -11.37M | $ -22.57M | $ 0 | $ -27.88M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -1.49 |
| Current Ratio | 0.97 |

## Other views

- [Metrics](https://sponda.capital/en/KPTI.md)
- [Charts](https://sponda.capital/en/KPTI/charts.md)
- [Compare](https://sponda.capital/en/KPTI/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.